[go: up one dir, main page]

AU2013201278A1 - Sp35 Antibodies and Uses Thereof - Google Patents

Sp35 Antibodies and Uses Thereof

Info

Publication number
AU2013201278A1
AU2013201278A1 AU2013201278A AU2013201278A AU2013201278A1 AU 2013201278 A1 AU2013201278 A1 AU 2013201278A1 AU 2013201278 A AU2013201278 A AU 2013201278A AU 2013201278 A AU2013201278 A AU 2013201278A AU 2013201278 A1 AU2013201278 A1 AU 2013201278A1
Authority
AU
Australia
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013201278A
Other versions
AU2013201278B2 (en
Inventor
Ellen A. Garber
Sha Mi
Steven D. Miklasz
R. Blake Pepinsky
Zhaohui Shao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008205244A external-priority patent/AU2008205244B2/en
Application filed by Biogen MA Inc filed Critical Biogen MA Inc
Priority to AU2013201278A priority Critical patent/AU2013201278B2/en
Priority claimed from AU2013201278A external-priority patent/AU2013201278B2/en
Publication of AU2013201278A1 publication Critical patent/AU2013201278A1/en
Application granted granted Critical
Publication of AU2013201278B2 publication Critical patent/AU2013201278B2/en
Assigned to BIOGEN MA INC. reassignment BIOGEN MA INC. Amend patent request/document other than specification (104) Assignors: BIOGEN IDEC MA INC.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013201278A 2007-01-09 2013-03-05 Sp35 Antibodies and Uses Thereof Ceased AU2013201278B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013201278A AU2013201278B2 (en) 2007-01-09 2013-03-05 Sp35 Antibodies and Uses Thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/879,324 2007-01-09
AU2008205244A AU2008205244B2 (en) 2007-01-09 2008-01-09 Sp35 antibodies and uses thereof
AU2013201278A AU2013201278B2 (en) 2007-01-09 2013-03-05 Sp35 Antibodies and Uses Thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008205244A Division AU2008205244B2 (en) 2007-01-09 2008-01-09 Sp35 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
AU2013201278A1 true AU2013201278A1 (en) 2013-05-02
AU2013201278B2 AU2013201278B2 (en) 2015-03-26

Family

ID=52727558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013201278A Ceased AU2013201278B2 (en) 2007-01-09 2013-03-05 Sp35 Antibodies and Uses Thereof

Country Status (1)

Country Link
AU (1) AU2013201278B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53058B (en) * 2005-07-08 2014-04-30 Biogen Idec Ma Inc. SP35 ANTIBODIES AND THEIR APPLICATIONS

Similar Documents

Publication Publication Date Title
HRP20180596T1 (en) Sp35 antibodies and uses thereof
EP2436696B8 (en) Anti-beta-amyloid antibody and uses thereof
IL195658A0 (en) Anti-nkg2a antibodies and uses thereof
ZA201003025B (en) Anti-hepcidin antibodies and uses thereof
IL235620A0 (en) Sp35 antibodies and uses thereof
IL196397A0 (en) Prlr-specific antibody and uses thereof
IL200012A0 (en) Anti-robo4 antibodies and uses therefor
AU2013201278A1 (en) Sp35 Antibodies and Uses Thereof
HK1137179A (en) Anti-robo4 antibodies and uses therefor
HK1130070A (en) Ephb3-specific antibody and uses thereof
HK1144397A (en) Anti-igf-1r antibodies and uses thereof
HK1145505A (en) Anti-chikungunya monoclonal antibodies and uses thereof
HK1138856A (en) C5 antigens and uses thereof
AU2006903659A0 (en) Antibodies and related methods
ZA200905136B (en) Anti-robo4 antibodies and uses therefor
HK1127361A (en) Anti-igf-ir antibodies and uses thereof
HK1109637A (en) Irta-2 antibodies and their uses
HK1152045A (en) Ron antibodies and uses thereof
HK1134496A (en) ANTIBODIES DIRECTED TO ALPHAVß6 AND USES THEREOF